A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
BioHealth Technologies Inc.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject must provide written informed consent prior to the conduct of any study
Male or female
18-65 years of age
Inclusive
Employed by one of seven selected Day Care Centers
You may not be if
Recent symptoms of upper respiratory infection, respiratory disease
Received medication for colds or allergies within 3 weeks of enrolling
Had nasal surgery within 2 months of enrolling
Had a pierced nose or wore nose jewelry
Clareo Health | A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers
